Heart Failure: The first human data on new HFpEF procedure | New HF guidelines | Congress investigating FDA

News You Need to Know Today

Friday, April 22, 2022

Editor's Choice: Heart Failure

Researchers share first human data on new interventional shunt procedure for HFpEF

The first-in-man study, completed by a team of cardiologists in China, included 10 patients presenting with HFpEF.

Researchers are using an intra-atrial shunt to lower pressures between the upper chambers of the heart to relieve symptoms in HFpEF heart failure patients. The novel Noya device uses an RF ablation to cut a hole into the septum and then enlarge it using a stent that can then be removed from the body after the procedure.

Researchers share first human data on new interventional shunt procedure for HFpEF

The first-in-man study, completed by a team of cardiologists in China, included 10 patients presenting with HFpEF.

Interventional cardiologists complete first heart procedure of its kind in North America

While the system used during the procedure has not yet gained full FDA approval, this patient was treated under a compassionate-use clearance from the agency.

TricValve Transcatheter Bicaval Valves System Cleveland Clinic. Image courtesy of P + F Products + Features GmbH.

Interventional cardiologists complete first heart procedure of its kind in North America

While the system used during the procedure has not yet gained full FDA approval, this patient was treated under a compassionate-use clearance from the agency.

Cardiology groups debut new heart failure guidelines ahead of ACC.22

The new recommendations went live just ahead of ACC.22. They can be read in full in the Journal of the American College of Cardiology, Circulation or Journal of Cardiac Failure.

Cardiology groups debut new heart failure guidelines ahead of ACC.22

The new recommendations went live just ahead of ACC.22. They can be read in full in the Journal of the American College of Cardiology, Circulation or Journal of Cardiac Failure.

Congress investigating FDA over heart device recall, says agency ‘failed to protect consumers’

“I am concerned by the FDA’s slow action, over multiple administrations, to protect patients from this product despite early warning signs,” one U.S. representative said in an open letter.

Congress investigating FDA over heart device recall, says agency ‘failed to protect consumers’

“I am concerned by the FDA’s slow action, over multiple administrations, to protect patients from this product despite early warning signs,” one U.S. representative said in an open letter.

An updated look at what cardiologists know about heart damage among COVID-19 patients

An international analysis published in Circulation and a new scientific statement from the American Heart Association both explore the latest data on heart complications associated with COVID-19.

Nurses caring for a COVID-19 patient in the COVID unit at Banner University Medical Center in Phoenix.

An updated look at what cardiologists know about heart damage among COVID-19 patients

An international analysis published in Circulation and a new scientific statement from the American Heart Association both explore the latest data on heart complications associated with COVID-19.

Cholesterol medications, flu shots and heart failure: Day 2 at ACC.22

Day 2 of ACC.22 was jam-packed with late-breaking clinical trials. Read our quick rundown of what researchers shared with the public for the very first time.

Steven E. Nissen, MD, discusses his late-breaking clinical trial with panelist Vera Bittner, MD.

Cholesterol medications, flu shots and heart failure: Day 2 at ACC.22

Day 2 of ACC.22 was jam-packed with late-breaking clinical trials. Read our quick rundown of what researchers shared with the public for the very first time.

Women who experience infertility may face higher heart failure risk

Researchers examined the health outcomes of 38,528 postmenopausal women—14% of whom had a history of infertility—over a 15-year period.

Patient doctor with masks. A team of specialists from Cleveland Clinic reviewed nearly 3,000 medications, writing that a common type 2 diabetes medication offered the most potential as an effective treatment for AFib.

Women who experience infertility may face higher heart failure risk

Researchers examined the health outcomes of 38,528 postmenopausal women—14% of whom had a history of infertility—over a 15-year period.

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us | Unsubscribe from all | Privacy Policy

© Innovate Healthcare, a TriMed Media brand

Editor's Choice: Heart Failure

Recent Newsletters